Osteoporosis treatment can be discontinued based on an individual assessment

Eiken, P.A.; Abrahamsen, B.

Ugeskrift for Laeger 179(2)

2017


ISSN/ISBN: 1603-6824
PMID: 28074765
Document Number: 692975
In most patients, treatment of osteoporosis is a long-term challenge. Because alendronate and zoledronic acid accumulate in bone with some persistent antifracture efficacy after therapy, it is reasonable to consider a "drug holiday" for low-risk patients. It is recommended that the duration and length of drug holiday should be individualized for each patient. For all other bisphosphonates data are limited. For other antiresorptive and anabolic agents "drug holiday" is not recommended.

Document emailed within 1 workday
Secure & encrypted payments